Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Replimune Group, Inc. | Director | Common Stock | 1.82M | $11.8M | $6.47 | May 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | May 16, 2024 | 1 | -$74.2K | 4 | May 20, 2024 | Director |
REPL | Replimune Group, Inc. | May 16, 2023 | 1 | -$142K | 4 | May 18, 2023 | President & Chief R&D Officer, Director |
REPL | Replimune Group, Inc. | Apr 1, 2023 | 2 | $0 | 4 | Apr 4, 2023 | President & Chief R&D Officer, Director |
REPL | Replimune Group, Inc. | May 16, 2022 | 1 | -$83.7K | 4 | May 18, 2022 | President & Chief R&D Officer, Director |
REPL | Replimune Group, Inc. | Apr 1, 2022 | 2 | $0 | 4 | Apr 5, 2022 | President & Chief R&D Officer, Director |
REPL | Replimune Group, Inc. | Jul 2, 2021 | 1 | -$313K | 4 | Jul 7, 2021 | President & Chief R&D Officer, Director |
REPL | Replimune Group, Inc. | Jun 28, 2021 | 2 | -$1.5M | 4 | Jun 30, 2021 | President & Chief R&D Officer, Director |